Skip to main content
Clinical Trials/NCT03042546
NCT03042546TerminatedPhase 4

Calcium Sulfate Spacer in Open Tibia Fractures With Sub-segmental Bone Loss to Decrease the Need for Secondary Surgery

University of Washington1 site in 1 country1 target enrollmentStarted: February 1, 2017Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Terminated
Enrollment
1
Locations
1
Primary Endpoint
Number of Patients With a Nonunion

Study Overview

Brief Summary

Investigators will compare antibiotic impregnated Calcium sulfate versus PMMA versus nothing in these sub-segmental bone defects.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Masking Description

Patients are blinded

Eligibility Criteria

Ages
16 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Open tibia shaft fracture treated with an IMN

Exclusion Criteria

  • Not provided

Arms & Interventions

Calcium Sulphate

Active Comparator

Intervention: Calcium Sulfate (Drug)

PMMA

Active Comparator

Intervention: PMMA (Drug)

Nothing

Active Comparator

Intervention: No treatment (Other)

Outcomes

Primary Outcomes

Number of Patients With a Nonunion

Time Frame: One Year

Radiographic healing at one year with no additional surgery

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Claude Sagi

Professor, Orthopedics

University of Washington

Study Sites (1)

Loading locations...

Similar Trials